Resources

Results 951 - 975 of 1223

This is the overall policy document for Waste Management and Safe Disposal of Pharmaceutical system for Afghanistan’s pharmaceutical sector. The goal of this document is to provide a comprehensive waste disposal system for medicines so as to ensure their safe destruction in a cost-effective and efficient manner; and to do this whilst also providing full protection of the environment.

This document is the overall policy for the product quality assurance (QA) system for Afghanistan’s pharmaceutical sector. This policy, the National Pharmaceutical Quality Assurance Policy, is part of continuous efforts by the Ministry of Public Health (MoPH) and stakeholders to ensure the safety, efficaciousness, and quality of medicines.

This framework seeks to outline a national strategy for the development of pharmaceutical HR in the public and private sectors in Afghanistan to produce a stronger pharmaceutical system that responds to the population’s needs. In particular, the framework serves as a reference document for the Human Resources for Health plan and the HR section of the National Medicines Policy of the MoPH.

This document aims to present a concept for the establishment of an independent NMHRA in the country, through which the regulatory activities of various MoPH authorities are coordinated and incorporated so that it is ensured that medical products are of a better quality and that the medicines consumed in the country are safe.

The National Medicine Board was established in 2003 and then it was promoted to the National Medicines & Food Board (NMFB) in 2009. According to the Medicine Law (2008), the Board is the highest decision making entity on issues related to pharmaceuticals. Upon its expansion in 2009, the Board’s mandate was extended to include foodstuff.

Each year the world loses 300,000 women and more than 2 million newborns to preventable causes related to pregnancy and childbirth. Millions of mothers in low-resource settings miss out on proper antenatal care, give birth without a skilled attendant, and don’t receive postpartum care for themselves or their babies.

In order to fight against future epidemics, the world must take action to prevent, detect, and respond to infectious disease outbreaks.   

Studies have shown that the role of a midwife before, during and after delivery can play a crucial role in preventing cross-infection between mother and baby. Mother-to-Child Transmission (MTCT) remains a serious threat, particularly with Zika and HIV viruses. Midwives have the power to change that. 

Once an outbreak becomes an epidemic, the costs - both human and financial - on health systems are extensive and debilitating. 

The list of 10 Core tests in each country includes six testing methods selected according to the International Health Regulations' immediately notifiable list and the WHO Top Ten Causes of Death in low-income countries. 

The Global Health Security Agenda (GHSA) was launched in February 2014 to help build countries’ capacity to help create a world safe and secure from infectious disease threats and elevate global health security as a national and global priority. Find out more about the GHSA Action Packages, visit: https://www.ghsagenda.org/ 

The Global Health Security Agenda (GHSA) was launched in February 2014 to help build countries’ capacity to help create a world safe and secure from infectious disease threats and elevate global health security as a national and global priority. Find out more about the GHSA, visit: https://www.ghsagenda.org/ 

Over half a billion people have died in epidemics over the last century and most experts agree another epidemic is not a matter of if, but a matter of when. Are you ready? This one page summary of Ready Together was presented at the 2017 Conference on Epidemic Preparedness held at Harvard Medical School.  

Between May and July of 2015, South Korea experienced an outbreak of Middle East respiratory syndrome, or MERS, that lead to 38 deaths and seriously affected the country's economy. 

The No More Epidemics campaign held its final event on November 13, 2017—the Ready Together Conference on Epidemic Preparedness, hosted in partnership with Harvard Medical School, Georgetown University’s Center for Global Health Science and Security, Harvard Global Health Institute, and the James M. and Cathleen D. Stone Foundation.

  Although international guidelines for tuberculosis (TB) control are standardized, country TB programs are often unable to properly manage the data needed for following the guidelines, resulting in poorly timed interventions.  

In his new book, 'The End of Epidemics: The Looming Threat to Humanity and How to Stop It,' Dr. Johnathan D. Quick, a Harvard Medical School faculty member and Chair of the Global Health Council, examines the eradication of smallpox and devastating effects of influenza, AIDS, SARS, and Ebola.

Since adopting Option B+ in 2011, Malawi has made significant progress in identifying and treating pregnant women living with HIV, thereby reducing vertical transmission. During the same time period, follow-up, diagnosis, and care of babies born to HIV-infected mothers also improved.

Malawi has a population of 18 million, with an adult HIV prevalence of 10.6%. The country has made remarkable progress toward achieving the UNAIDS 90-90-90 goals, achieving the first goal remains a challenge. The Malawi HIV program estimated Malawi’s progress on achieving the 90-90-90 goals at 88-78-86 by June 2017.

Malawi adopted the 90-90-90 strategy as part of the National Strategic Plan to end HIV/AIDS by 2030 which calls for: identifying 90% of people living with HIV (PLHIV); initiating and retaining on antiretroviral therapy (ART) 90% of PLHIV identified; and achieving 90% viral suppression for ART patients.

Malawi is among the countries hardest hit by the HIV pandemic. The country has a national HIV prevalence rate of 10.6% of the adult population aged 15–64 years (12.8% women vs 8.2% in men). With 85% of Malawians living in rural areas, access to health services is difficult because of long distances, poverty, and other social factors.

HIV has been a global challenge over the past several decades, particularly in developing countries such as Malawi, where adult HIV prevalence is about 10.6%.

Malawi has a significant youth and adolescent population, with nearly two-thirds of the country’s estimated 17.2 million people under the age of 24. Youth and adolescents, aged 10-24, account for about 50% of new HIV infections in Malawi.

Cervical cancer affects an estimated 527,624 women worldwide each year, killing more than half of them. About 85% of the global disease burden occurs in developing countries, and Southern Africa is one of the highest-risk regions in the world.

Since the 1990s, the Inter-agency field manual on reproductive health in humanitarian settings (IAFM) has provided authoritative guidance on reproductive health service provision during different phases of complex humanitarian emergencies. In 2018, the Inter-Agency Working Group on Reproductive Health in Crises will release a new edition of this global resource. In this article, we describe the collaborative and inter-sectoral revision process and highlight major changes in the 2018 IAFM. We conclude with an outline of plans for releasing the 2018 IAFM and facilitating uptake by those working in refugee, crisis, conflict, and emergency settings.

Pages